$20.81+0.03 (+0.14%)
Sabra Health Care REIT, Inc.
Sabra Health Care REIT, Inc. in the Real Estate sector is trading at $20.81 with a market capitalization of $5.2B. Wall Street consensus targets $22.79 (14 analysts), implying a +9.5% move over the next 12 months. The stock is currently 9% below its 52-week high of $22.77, remaining 7.6% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $235.87M↑ | $221.75M↑ | $211.90M↑ | $190.04M↑ | $189.15M |
| Gross Profit | $143.59M↑ | $136.11M↑ | $131.49M↑ | $120.38M↓ | $128.05M |
| Operating Income | -$32.05M↓ | $68.33M↑ | $64.58M↑ | $59.55M↓ | $71.95M |
| Net Income | -$25.20M↓ | $40.88M↑ | $27.23M↑ | $22.54M↓ | $65.54M |
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Hea...

Your money-market fund is now yielding more than inflation, if only by a hair. “Nothing” seems to be the answer from those individuals who keep $3 trillion stashed in money funds yielding about 3.5%, 10 basis points more than the 3.4% increase in the consumer price index in the latest 12 months, but less than that after rendering unto Uncle Sam.
Managed senior housing transition drives gains amid record investment pipeline activity.
Wall Street analysts made some dramatic moves on Thursday, slashing price targets by double digits on several high-profile names while upgrading others to buy. Find out which stocks got the most surprising treatment before the opening bell.
Sabra Health Care REIT (SBRA) is back in focus after its latest quarterly update. The company reported higher normalized AFFO, reaffirmed an improved 2026 outlook, highlighted lower leverage and kept its dividend unchanged. See our latest analysis for Sabra Health Care REIT. Sabra Health Care REIT's recent earnings update and reaffirmed 2026 outlook come after a period where momentum has been building. The share price is up 10.08% year to date with a 6.84% 1 month share price return, while...
Sabra Health Care REIT Inc (SBRA) reports robust Q2 2026 results with normalized AFFO per share up 5% year-over-year, significant leverage reduction, and a $1 billion investment pipeline.